サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701979

組織工学市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

Tissue Engineering Market Report by Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
組織工学市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組織工学市場の世界市場規模は2024年に200億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに510億米ドルに達し、2025年から2033年にかけて10.9％の成長率（CAGR）を示すと予測しています。この市場を牽引しているのは、再生医療やTEの需要の増加、交通事故や外傷による死亡事故の増加、患者における骨インプラントのニーズの増大、3次元（3D）組織工学分野における継続的な技術進歩、医療支出の増加などです。

組織工学（TE）は、細胞、足場、生物学的に活性な分子を組み合わせて機能的な組織を作る生物医学工学の一分野です。生命科学と工学の原理を応用し、さまざまな種類の組織や臓器を回復、改善、維持、置換するための生物学的代替物を開発します。損傷した組織を修復するために用いられる移植、外科的再建術、その他の機械的装置に代わる効率的な代替手段を提供します。その結果、組織工学は、火傷治療、神経学、創傷治療、整形外科、筋骨格系、心臓血管系、泌尿器系など、数多くの医療用途で急速に普及しています。現在、研究者は、比較的安価で入手しやすい皮膚代替製品に対する需要の高まりに応えるため、皮膚代替用の生体材料の開発に注力しています。

組織工学市場傾向：

組織工学的処置は、組織の不可逆的損傷の治療に有効であることが証明されています。このため、再生医療や組織工学的処置に対する需要が大幅に増加しており、これが市場成長を牽引する主な要因となっています。このほか、交通事故や外傷による死亡率の上昇、患者の間で骨インプラントのニーズが高まっていることも、製品需要を増大させています。さらに、座りっぱなしの生活習慣、高齢化、不健康な食生活により、糖尿病、がん、肥満、心血管障害などの慢性疾患が広く蔓延していることも、市場の成長を促しています。さらに、臓器オンチップ技術、胚細胞と幹細胞の置換、体外インプラントを効率的に設計するための3Dバイオプリンターの使用など、3次元（3D）組織工学の分野における技術進歩が、市場に有利な機会をもたらしています。さらに、いくつかの製品イノベーション、研究開発（R&D）活動への政府資金や民間投資の増加が市場成長を後押ししています。その他にも、人工関節置換術や再建術の増加、消費者の医療支出の増加、形成外科手術の需要急増などが、市場の見通しを明るいものにしています。

本レポートで扱う主な質問

  • 2024年の世界の組織工学市場の市場規模は？
  • 2025-2033年における組織工学市場の世界市場成長率は？
  • 世界の組織工学市場を牽引する主要因は何か？
  • 世界の組織工学市場に対するCOVID-19の影響は？
  • 世界の組織工学市場のタイプ別内訳は？
  • 世界の組織工学市場の用途別内訳は？
  • 世界の組織工学市場における主要地域は？
  • 世界の組織工学市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の組織工学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 合成スキャフォールド材料
  • 生物由来スキャフォールド材料
  • その他

第7章 市場内訳：用途別

  • 整形外科・筋骨格系
  • 神経系
  • 心血管系
  • 皮膚・外皮系
  • 歯科系
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 外来施設

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc
    • Becton, Dickinson and Company
    • Integra LifeSciences Corporation
    • Organogenesis Holdings Inc
    • RTI Surgical
    • Smith & Nephew plc
    • Stryker Corporation
    • Vericel Corporation
    • Zimmer Biomet
図表

List of Figures

  • Figure 1: Global: Tissue Engineering Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Engineering Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Tissue Engineering Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Tissue Engineering Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Tissue Engineering Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Tissue Engineering Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Tissue Engineering Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Tissue Engineering (Synthetic Scaffold Material) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Tissue Engineering (Synthetic Scaffold Material) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Tissue Engineering (Biologically Derived Scaffold Material) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Tissue Engineering (Biologically Derived Scaffold Material) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Tissue Engineering (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Tissue Engineering (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Tissue Engineering (Orthopedics and Musculoskeletal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Tissue Engineering (Orthopedics and Musculoskeletal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Tissue Engineering (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Tissue Engineering (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Tissue Engineering (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Tissue Engineering (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Tissue Engineering (Skin and Integumentary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Tissue Engineering (Skin and Integumentary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Tissue Engineering (Dental) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Tissue Engineering (Dental) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Tissue Engineering (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Tissue Engineering (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Tissue Engineering (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Tissue Engineering (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Tissue Engineering (Ambulatory Facilities) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Tissue Engineering (Ambulatory Facilities) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Tissue Engineering Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Tissue Engineering Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Tissue Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Tissue Engineering Industry: SWOT Analysis
  • Figure 80: Global: Tissue Engineering Industry: Value Chain Analysis
  • Figure 81: Global: Tissue Engineering Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tissue Engineering Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Tissue Engineering Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Tissue Engineering Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Tissue Engineering Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Tissue Engineering Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Tissue Engineering Market: Competitive Structure
  • Table 7: Global: Tissue Engineering Market: Key Players
目次
Product Code: SR112025A4880

The global tissue engineering market size reached USD 20.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.0 Billion by 2033, exhibiting a growth rate (CAGR) of 10.9% during 2025-2033. The market is driven by the increasing demand for regenerative medicines and TE procedures, rising incidences of fatal road accidents and trauma injuries, the augmenting need for bone implants among patients, continual technological advancements in the field of three-dimensional (3D) tissue engineering, and rising healthcare expenditure.

Tissue engineering (TE) is a biomedical engineering discipline that combines cells, scaffolds, and biologically active molecules into functional tissues. It applies the principles of life sciences and engineering to develop biological substitutes to restore, improve, maintain, or replace different types of tissues or organs. It provides efficient alternatives to transplants, surgical reconstruction procedures, and other mechanical devices that are used to repair damaged tissues. As a result, tissue engineering is rapidly gaining traction in numerous medical applications, including burn treatment, neurology, wound care, orthopedic, musculoskeletal, cardiovascular, and urological products. Nowadays, researchers are focusing on developing biomaterials for skin substitution to meet the growing demand for relatively cheaper and easily available skin replacement products.

Tissue Engineering Market Trends:

Tissue engineering procedures have proven effective in treating irreversible damage to tissues. This has led to a significant increase in the demand for regenerative medicines and TE procedures, which represents the primary factor driving the market growth. Besides this, the rising incidences of fatal road accidents and trauma injuries, along with the growing need for bone implants among patients, are augmenting the product demand. Additionally, the widespread prevalence of chronic diseases, such as diabetes, cancer, obesity and cardiovascular disorders, due to sedentary lifestyle habits, aging population and unhealthy diets, is catalyzing the market growth. Furthermore, technological advancements in the field of three-dimensional (3D) tissue engineering, such as organ-on-a-chip technology, replacement of embryo cells with stem cells, and use of 3D bioprinters to design in vitro implants efficiently, are offering lucrative opportunities to the market. Moreover, several product innovations, and the increasing government funding and private investments in research and development (R&D) activities are propelling the market growth. Other factors, including the growing number of replacements and reconstructive surgeries, rising consumer healthcare expenditure, and surging demand for plastic surgeries, are also creating a positive market outlook.

Key Market Segmentation:

Breakup by Type:

  • Synthetic Scaffold Material
  • Biologically Derived Scaffold Material
  • Others

Breakup by Application:

  • Orthopedics and Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin and Integumentary
  • Dental
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Facilities

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Integra LifeSciences Corporation, Organogenesis Holdings Inc, RTI Surgical, Smith & Nephew plc, Stryker Corporation, Vericel Corporation and Zimmer Biomet.

Key Questions Answered in This Report

  • 1.What was the size of the global tissue engineering market in 2024?
  • 2.What is the expected growth rate of the global tissue engineering market during 2025-2033?
  • 3.What are the key factors driving the global tissue engineering market?
  • 4.What has been the impact of COVID-19 on the global tissue engineering market?
  • 5.What is the breakup of the global tissue engineering market based on the type?
  • 6.What is the breakup of the global tissue engineering market based on the application?
  • 7.What are the key regions in the global tissue engineering market?
  • 8.Who are the key players/companies in the global tissue engineering market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Engineering Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Synthetic Scaffold Material
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biologically Derived Scaffold Material
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Orthopedics and Musculoskeletal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Skin and Integumentary
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Dental
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Facilities
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton, Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra LifeSciences Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Organogenesis Holdings Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 RTI Surgical
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Smith & Nephew plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vericel Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Zimmer Biomet
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis